TrialArthritis & rheumatology (Hoboken, N.J.)2019

Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti-IgE Monoclonal Antibody in Systemic Lupus Erythematosus.

Sarfaraz Hasni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.